학술논문
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial
Document Type
Article
Author
Source
In The Lancet 6-12 June 2015 385(9984):2272-2279
Subject
Language
ISSN
0140-6736